Literature DB >> 21868579

Angiopoietin-2 promotes myeloid cell infiltration in a β₂-integrin-dependent manner.

Alexander Scholz1, Victoria Lang, Reinhard Henschler, Marcus Czabanka, Peter Vajkoczy, Emmanouil Chavakis, Janina Drynski, Patrick N Harter, Michel Mittelbronn, Daniel J Dumont, Karl H Plate, Yvonne Reiss.   

Abstract

In human inflammatory diseases, we identified endothelial angiopoietin-2 (Ang-2) expression to be strongly associated with inflammations mediated by myeloid cells but not lymphocytes. To identify the underlying mechanism, we made use of a transgenic mouse model with inducible endothelial cell-specific expression of Ang-2. In this model, in the absence of inflammatory stimuli, long-term expression of Ang-2 led to a time-dependent accumulation of myeloid cells in numerous organs, suggesting that Ang-2 is sufficient to recruit myeloid cells. In models of acute inflammation, such as delayed-type hypersensitivity and peritonitis, Ang-2 transgenic animals showed an increased responsiveness. Intravital fluorescence video microscopy revealed augmented cell adhesion as an underlying event. Consequently, we demonstrated that Ang-2 is able to induce strong monocyte adhesion under shear in vitro, which could be blocked by antibodies to β₂-integrin. Taken together, our results describe Ang-2 as a novel, endothelial-derived regulator of myeloid cell infiltration that modulates β₂-integrin-mediated adhesion in a paracrine manner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868579     DOI: 10.1182/blood-2011-03-343293

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.

Authors:  Jing-Si Wang; Qiu-Yun Zhang; Jin-Lian Cheng; Lan-Yu Chen; Nai-Li Yao; Gui-Zhi Sun; Yu-Ling Chu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

3.  Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.

Authors:  Xinqi Wu; Anita Giobbie-Hurder; Xiaoyun Liao; Courtney Connelly; Erin M Connolly; Jingjing Li; Michael P Manos; Donald Lawrence; David McDermott; Mariano Severgnini; Jun Zhou; Evisa Gjini; Ana Lako; Mikel Lipschitz; Christine J Pak; Sara Abdelrahman; Scott Rodig; F Stephen Hodi
Journal:  Cancer Immunol Res       Date:  2016-12-21       Impact factor: 11.151

Review 4.  Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa.

Authors:  Kabir A Khan; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2018-02-13       Impact factor: 66.675

Review 5.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

6.  The role of angiopoietin-2 in nucleus pulposus cells during human intervertebral disc degeneration.

Authors:  Kun Wang; Wei Liu; Yu Song; Xinghuo Wu; Yukun Zhang; Shuai Li; Yong Gao; Ji Tu; Yingle Liu; Cao Yang
Journal:  Lab Invest       Date:  2017-04-10       Impact factor: 5.662

7.  Chlorinated Lipids Elicit Inflammatory Responses in vitro and in vivo.

Authors:  Hong Yu; Meifang Wang; Derek Wang; Theodore J Kalogeris; Jane McHowat; David A Ford; Ronald J Korthuis
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

8.  Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis.

Authors:  Elif Birtas Atesoglu; Pinar Tarkun; Ozgur Mehtap; Esra Terzi Demirsoy; Figen Atalay; Muhammet Maden; Koray Celebi; Abdullah Hacihanefioglu
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-16       Impact factor: 0.900

9.  Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.

Authors:  Sarah B Mueller; Christopher D Kontos
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

10.  Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth.

Authors:  Xiaolan Yu; Jingfeng Sha; Shao Xiang; Sanhai Qin; Patricia Conrad; Santosh K Ghosh; Aaron Weinberg; Fengchun Ye
Journal:  Cell Cycle       Date:  2016-06-13       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.